Media centre

Press releases and news

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

AstraZeneca launches integrated genomics approach to transform drug discovery and development

AstraZeneca showcases breadth of Oncology portfolio at AACR 2016 Annual Meeting

Brilinta preferred over clopidogrel in updated American College of Cardiology and American Heart Association guideline in acute coronary syndrome

Video gallery

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

CRISPR technology for genome editing

CRISPR, a pioneering genome-editing technique, technology will allow AstraZeneca to identify and validate new drug targets in preclinical models that closely resemble human disease.

 

  • Download

    •  

     

    Advancing the science of cancer diagnosis

    Learn how we are advancing the science of cancer diagnosis, and making biopsies easier for patients, through the diagnosis of circulating tumour DNA in blood samples.

     
     

    AstraZeneca, designs for new Cambridge site

    AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK